Sudha Khurana

Title: Sudha Khurana: Innovator in Angiogenesis Research

Introduction

Sudha Khurana is a prominent inventor based in Santa Clara, CA (US). She has made significant contributions to the field of angiogenesis research, holding a total of 4 patents. Her work focuses on developing innovative solutions for diagnosing and treating diseases associated with angiogenesis.

Latest Patents

Among her latest patents are the KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy. This invention provides polypeptides, peptide dimers, and multimeric complexes that include at least one binding moiety for the KDR or VEGF/KDR complex. These innovations have a variety of applications in treating, detecting, isolating, or localizing angiogenesis, which is crucial in conditions such as cancer. The synthetic, isolated polypeptides are capable of binding to the KDR or VEGF/KDR complex with high affinity, making them valuable in therapeutic contexts.

Career Highlights

Throughout her career, Sudha Khurana has worked with notable companies, including Bracco Suisse SA and Dyax Corporation. Her experience in these organizations has contributed to her expertise in the field of biomedical research and innovation.

Collaborations

Sudha has collaborated with esteemed colleagues such as Christophe Arbogast and Philippe Bussat. These partnerships have further enhanced her research and development efforts in the area of angiogenesis.

Conclusion

Sudha Khurana's contributions to the field of angiogenesis research through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in diagnosis and therapy for diseases related to angiogenesis.